Summary
have been approved for use on the NHS, the health watchdog said.
Thalidomide and Velcade (bortezomib) will be made available for some patients with multiple myeloma, according to the National Institute Health and Clinical Excellence (Nice).See the full content of this document
Extract
Have Been Approved for Use [ ... ]
Up to 4,000 people a year...
See the full content of this document
Sponsored links
